Literature DB >> 10026311

Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.

S Schreiber1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10026311      PMCID： PMC1727408          DOI： 10.1136/gut.44.3.309

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  28 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

5.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

Authors:  S Nicholls; S Stephens; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

7.  Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter.

Authors:  S Takashiba; T E Van Dyke; L Shapira; S Amar
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

9.  Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.

Authors:  K Wiegmann; S Schütze; T Machleidt; D Witte; M Krönke
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

10.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

Authors:  M J Yin; Y Yamamoto; R B Gaynor
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962
View more
  3 in total

Review 1.  Therapeutic targets to reduce cardiovascular disease in type 2 diabetes.

Authors:  Cyrus DeSouza; Vivian Fonseca
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

2.  Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells.

Authors:  Jingwen Zhang; Wen Wu; Dongfeng Li; Ying Guo; Helin Ding
Journal:  Endocrine       Date:  2009-11-24       Impact factor: 3.633

3.  Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF).

Authors:  Julia Brenmoehl; Werner Falk; Michael Göke; Jürgen Schölmerich; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2008-07-17       Impact factor: 2.571
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.